Phase 4, Post-Marketing Safety Surveillance of the MF59-Adjuvanted Influenza Vaccines FLUAD® and VANTAFLU® in South Korean Subjects Aged ≥65 Years
暂无分享,去创建一个
C. O. Kim | A. Izu | A. Arora | E. Heijnen | Byung Wook Yoo | B. W. Yoo | C. Kim | B. Yoo
暂无分享,去创建一个
C. O. Kim | A. Izu | A. Arora | E. Heijnen | Byung Wook Yoo | B. W. Yoo | C. Kim | B. Yoo